Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Best duration for postpartum remote blood pressure monitoring

Official title: HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

Run by University of Minnesota · NCT07204756 · Data updated 2026-11-12

This tests whether 2 weeks or 6 weeks of remote blood pressure monitoring after delivery works better for people who had hypertensive disorders of pregnancy.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment400 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedJanuary 7, 2026
Main results expectedJanuary 31, 2028
Study endsJanuary 31, 2028
Registry record updatedJanuary 14, 2026
Trial IDNCT07204756 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) discharged after delivery from the University of Minnesota who enrolled in the HOPE-BP program and who are not taking antihypertensive medication at two weeks are ideal candidates.

Probably not a fit

People who remain on antihypertensive medications at two weeks, have medical comorbidities that preclude randomization, or who did not enroll in HOPE-BP are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study at the University of Minnesota enrolls postpartum patients with hypertensive disorders who are participating in the HOPE-BP remote monitoring program. At two weeks after delivery, eligible participants who are not on ongoing antihypertensive medication are randomized to either stop monitoring at 2 weeks or continue monitoring through 6 weeks. Clinical outcomes for the two monitoring durations are compared to determine differences in postpartum blood pressure control and related complications. The aim is to identify the monitoring length that best supports patient safety and efficient postpartum care at the institution.

Why it matters

Potential benefit: If successful, the results could identify the optimal monitoring length to reduce postpartum complications and unnecessary follow-up.

How similar studies have gone: Remote postpartum blood pressure monitoring programs have been widely adopted and vary between 2 and 6 weeks, but a randomized comparison of optimal duration is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Discharged after delivery at University of Minnesota Medical Center
* Enrolled into the HOPE-BP Program

Exclusion Criteria:

* Ongoing antihypertensive medication use at 2 weeks (time of randomization)
* Have a medical comorbidity that would not be clinically appropriate to randomize
* Patients opted out of clinical research

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Bethany Sabol, MD MAS — University of Minnesota
  • Study coordinator: Erin Linden
  • Email: linde491@umn.edu
  • Phone: 612-625-2273

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.